会员体验
专利管家(专利管理)
工作空间(专利管理)
风险监控(情报监控)
数据分析(专利分析)
侵权分析(诉讼无效)
联系我们
交流群
官方交流:
QQ群: 891211   
微信请扫码    >>>
现在联系顾问~
热词
    • 72. 发明授权
    • Trocar site closure assembly
    • 套管针座闭合装配
    • US09463019B2
    • 2016-10-11
    • US14279765
    • 2014-05-16
    • University of Louisville Research Foundation, Inc.
    • Daniel S. MetzingerRobert S. KeyntonScott D. Cambron
    • A61B17/08A61D1/00A61B17/00
    • A61B17/08A61B17/0057A61B2017/00592A61B2017/00619A61B2017/00623A61B2017/00637A61B2017/081
    • Embodiments of this invention relate to trocar site closures including a head with a plurality of arm receiving passages therethrough, an arm received by each of the passages, each passage having a discontinuity which allows each arm to be pulled inward but deters outward movement, and each arm having a grappling portion. The head and arms are inserted into a patient wound, such as a trocar site. The arms engage with tissue surrounding the wound. A pulling force is exerted on the arm proximal ends, drawing the distal ends of the arms toward the head and at least partially closing the wound. The head and at least a portion of the arms remain in the patient, and are preferably made of a biocompatible material. Embodiments of this invention also relate to an insertion device used to insert the closure into the wound and at least partially close the wound.
    • 本发明的实施例涉及套管针位置闭合,其包括具有多个臂接收通道的头部,由每个通道接收的臂,每个通道具有不连续性,其允许每个臂向内拉动但阻止向外移动,并且每个 臂具有抓钩部分。 头部和手臂插入患者伤口,如套管针部位。 手臂与伤口周围的组织接合。 牵引力作用在臂的近端,将臂的远端朝头部拉出并且至少部分地闭合伤口。 头部和至少一部分臂保持在患者体内,并且优选地由生物相容性材料制成。 本发明的实施例还涉及用于将闭合件插入伤口并且至少部分地闭合伤口的插入装置。
    • 80. 发明授权
    • Olfactory epithelial-derived stem cells and methods of use therefor
    • 嗅上皮衍生的干细胞及其使用方法
    • US09090874B2
    • 2015-07-28
    • US13127142
    • 2009-11-02
    • Fred J. RoisenChengliang LuMeng WangMengsheng Qiu
    • Fred J. RoisenChengliang LuMeng WangMengsheng Qiu
    • C12N5/0793A61K35/12
    • C12N5/0619A61K35/12C12N2501/01C12N2501/38C12N2501/385C12N2501/41C12N2501/60C12N2510/00
    • The presently disclosed subject matter provides recombinant dopaminergic neurons and/or recombinant progenitors thereof that include one or more transgenes encoding a nurr-1 polypeptide, a pitx3 polypeptide, an Imxi a polypeptide, a biologically active fragment thereof, a biologically active derivative thereof, and/or any combination thereof. Also provided are methods for producing a recombinant dopaminergic neuron or recombinant progenitor thereof, methods for producing lineage primed cells, methods for ameliorating at least one symptom associated with a neurological disorder, methods for transplantation, methods for inducing growth, repair, ancllor regeneration of a neuron, for delivering a cytokine or a growth factor to the central nervous system, methods for providing a dopaminergic neuron function, and cell cultures that include recombinant olfactory epithelial-derived stem cells and/or a differentiated derivatives thereof.
    • 目前公开的主题提供了重组多巴胺能神经元和/或其重组祖细胞,其包含编码Nurr-1多肽,pitx3多肽,Imxi一种多肽,其生物活性片段,其生物活性衍生物的一种或多种转基因,和 /或其任何组合。 还提供了用于产生重组多巴胺能神经元或其重组祖细胞的方法,用于产生谱系引发细胞的方法,用于改善与神经障碍相关的至少一种症状的方法,用于移植的方法,诱导生长的方法,修复,祖细胞再生 用于将细胞因子或生长因子递送至中枢神经系统的神经元,用于提供多巴胺能神经元功能的方法,以及包含重组嗅上皮来源的干细胞和/或其分化衍生物的细胞培养物。